Filbrandt Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$67K Buy
317
+4
+1% +$921 0.04% 77
2021
Q2
$76K Hold
313
0.04% 66
2021
Q1
$78K Buy
313
+13
+4% +$3.1K 0.05% 63
2020
Q4
$69K Hold
300
0.04% 68
2020
Q3
$76K Sell
300
-614
-67% -$152K 0.06% 61
2020
Q2
$216K Buy
914
+614
+205% +$140K 0.17% 37
2020
Q1
$61K Hold
300
0.07% 58
2019
Q4
$72K Buy
+300
New +$66.1K 0.06% 60

Other funds holding AMGN

Filbrandt Wealth Management's AMGN Position: Q3 2021 in Review

Filbrandt Wealth Management increased its Amgen (AMGN) stake by 1.3% in Q3 2021, buying an estimated $921 and bringing the position to 317 shares worth $67K. The position accounts for 0.04% of the portfolio, ranked #77.

Filbrandt Wealth Management first reported a position in AMGN in Q4 2019 and has held it in 8 quarters since. The position peaked at $216K in Q2 2020. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Filbrandt Wealth Management held 317 shares of Amgen worth $67K as of Q3 2021.
  • Filbrandt Wealth Management bought 4 Amgen shares in Q3 2021, an estimated $921.
  • Amgen made up 0.04% of Filbrandt Wealth Management's portfolio in Q3 2021, its #77 holding.
  • Filbrandt Wealth Management first reported a position in Amgen in Q4 2019 and has held it in 8 quarters since.
  • Filbrandt Wealth Management's Amgen position peaked at $216K in Q2 2020.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Filbrandt Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.